Concepedia

Heather K. Webb

HK

Statistics

Publications

25

Citations

2.5K

H-Index

22

Active since

1992

Affiliations

Areté Associates (United States)(Current)

Dana-Farber Cancer Institute

Stanford University

Harvard University

Cornell University

Heather K. Webb is an author at Areté Associates (United States) specializing in pharmacology, medicine, and cancer pharmacology.

Publications per year

1992–2018

25

Publications

25

Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia

Jennifer R. Brown, John C. Byrd, Steven Coutré et al. · Blood · 2014 · 584 citations · Full text

Medicine, Oncology, Pharmacology +14

Diverse Roles of the Nuclear Orphan Receptor CAR in Regulating Hepatic Genes in Response to Phenobarbital

Akiko Ueda, Hisham K. Hamadeh, Heather K. Webb et al. · Molecular Pharmacology · 2002 · 466 citations

Medicine, Molecular Biology, Pharmacology +17

Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma

Ian W. Flinn, Brad S. Kahl, John P. Leonard et al. · Blood · 2014 · 209 citations · Full text

Medicine, Oncology, Pharmacology +11

Pharmacokinetics and Pharmacodynamics of AR9281, an Inhibitor of Soluble Epoxide Hydrolase, in Single‐ and Multiple‐Dose Studies in Healthy Human Subjects

Dawn Chen, Randall Whitcomb, Euan MacIntyre et al. · The Journal of Clinical Pharmacology · 2011 · 147 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

CAL-101, An Isoform-Selective Inhibitor of Phosphatidylinositol 3-Kinase P110δ, Demonstrates Clinical Activity and Pharmacodynamic Effects In Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia

Richard R. Furman, John C. Byrd, Jennifer R. Brown et al. · Blood · 2010 · 124 citations

Medicine, Oncology, Pharmacology +12

1–5 of 25